Afatinib for an elderly patient with chronic kidney disease

被引：1

作者：

Okauchi, S. ^{[1
]}

Hagimoto, S. ^{[1
]}

Osawa, H. ^{[1
]}

Ohara, G. ^{[1
]}

Satoh, H. ^{[1
]}

机构：

[1] Univ Tsukuba, Mito Kyodo Gen Hosp, Mito Med Ctr, Div Resp Med, Miya Machi 3-2-7, Mito, Ibaraki 3100015, Japan

来源：

EUROPEAN GERIATRIC MEDICINE | 2017年 / 8卷 / 02期

关键词：

Afatinib; Lung cancer; Chronic kidney disease; HEMODIALYSIS;

D O I：

10.1016/j.eurger.2017.01.006

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

引用

页码：104 / 104

页数：1

共 4 条

[1]

Bersanelli M, 2014, ANTICANCER RES, V34, P3185

[2] Successful afatinib treatment of advanced non-small-cell lung cancer patients undergoing hemodialysis [J].

Imai, Hisao ;

Kaira, Kyoichi ;

Naruse, Ichiro ;

Hayashi, Hideki ;

Iihara, Hirotoshi ;

Kita, Yutaro ;

Mizusaki, Naoki ;

Asao, Takayuki ;

Itoh, Yoshinori ;

Sugiyama, Tadashi ;

Minato, Koichi ;

Yamada, Masanobu .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (01) :209-213

[3] Afatinib: A Review in Advanced Non-Small Cell Lung Cancer [J].

Keating, Gillian M. .

TARGETED ONCOLOGY, 2016, 11 (06) :825-835

[4] Afatinib pharmacokinetics and metabolism after oral administration to healthy male volunteers [J].

Stopfer, Peter ;

Marzin, Kristell ;

Narjes, Hans ;

Gansser, Dietmar ;

Shahidi, Mehdi ;

Uttereuther-Fischer, Martina ;

Ebner, Thomas .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (04) :1051-1061

← 1 →